These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22839590)

  • 41. [Therapy for hypertension associated with ischemic heart disease].
    Kawano H
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):250-7. PubMed ID: 12652729
    [No Abstract]   [Full Text] [Related]  

  • 42. [Changes in the renin-angiotensin system and the effectiveness of the treatment of hypertension with calcium antagonists, beta-adrenoblockers and diuretics].
    Svishchenko EP
    Kardiologiia; 1992 Sep; 32(9-10):41-4. PubMed ID: 1363127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium channel blocker debate: true lies?
    Leor J; Battler A
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):413-5. PubMed ID: 8924054
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of beta-blockade in modern cardiovascular therapy. Proceedings of the 3rd International Symposium on Bisoprolol. Barcelona, Spain, September 29-October 1, 1989.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-212. PubMed ID: 11572202
    [No Abstract]   [Full Text] [Related]  

  • 46. [Alpha blocker x beta-blocker].
    Ishikawa J; Kario K
    Nihon Rinsho; 2014 Aug; 72(8):1485-9. PubMed ID: 25167757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease].
    Tsvetkova OA; Veselovskaia MV
    Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical evaluation of the effectiveness of combined use of local and general hypotensive agents in patients with glaucoma and hypertension].
    Zakharova IA; Makhmutov VIu; Pristavka VA; Kul'kova SV
    Vestn Oftalmol; 2002; 118(1):44-6. PubMed ID: 11898362
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treating hypertension in patients with ischaemic disease: the case for better beta-blocker usage.
    Cardiovasc J Afr; 2008; 19(2):113. PubMed ID: 18516359
    [No Abstract]   [Full Text] [Related]  

  • 52. Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications.
    Kishi T; Fujii E
    Hypertens Res; 2019 Apr; 42(4):496-503. PubMed ID: 30948819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of bisoprolol and its effect on dialysis refractory hypertension.
    Kanegae K; Hiroshige K; Suda T; Iwamoto M; Ohta T; Nakashima Y; Ohtani A
    Int J Artif Organs; 1999 Dec; 22(12):798-804. PubMed ID: 10654875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Direction of pharmacotherapeutic changes used in cardiovascular diseases assessed by examination of two population samples from Warsaw].
    Kuźmińska A; Pìotrowski W; Rywik S; Broda G; Polakowska M
    Pol Arch Med Wewn; 1994 Dec; 92(6):489-98. PubMed ID: 7716052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From beta blockers to Ca2+ blockers in hypertension: a review.
    Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Jul; 18(7):735-9. PubMed ID: 6125488
    [No Abstract]   [Full Text] [Related]  

  • 59. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of hypertension with calcium antagonists.
    Murphy MB
    Int J Clin Pharmacol Res; 1985; 5(5):287-91. PubMed ID: 2866165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.